The effect of topical caffeine on the morphology of swine hypodermis as measured by ultrasound

Journal of Cosmetic Dermatology

Volumn 7, Issue 3, 2008, Pages 232-237

  Pires e Campos, Maria Silvia Mariani ^a,b   Leonardi, Gislaine Ricci ^b   Chorilli, Marlus ^b   Spadari Bratfisch, Regina Célia ^a   Polacow, Maria Luiza Ozores ^b   Grassi Kassisse, Dora Maria ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b METHODIST UNIVERSITY OF PIRACICABA   (Brazil)

Author keywords

Adipose tissue; Caffeine; Phonophoresis

Indexed keywords

CAFFEINE; EOSIN; HEMATOXYLIN;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN PENETRATION; SKINFOLD THICKNESS; STAINING; SUBCUTANEOUS TISSUE; SWINE; ULTRASOUND THERAPY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DATA INTERPRETATION, STATISTICAL; MALE; PROPYLENE GLYCOL; SOLVENTS; STATISTICS, NONPARAMETRIC; SUBCUTANEOUS TISSUE; SUS SCROFA; SWINE; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 48949102995     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2008.00397.x     Document Type: Article

References (37)

1. Terranova F, Berardesca E, Maibach H. Cellulite: Nature and aetiopathogenesis. Int J Cosmet Sci 2006; 28: 157-67.
2. Draelos ZD. The disease of cellulite. J Cosmet Dermatol 2005; 4: 221-2.
3. Lotti T, Ghersetich I, Grappone C, Dini G. Proteoglycans in so-called cellulite. Int J Dermatol 1990; 29: 272-4.
4. Curri SB. Cellulite and fatty tissue microcirculation. Cosmet Toilet 1993; 108: 51-8.
5. Rosenbaum M, Prieto V, Hellmer J. et al. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg 1998; 101: 1934-9.
6. Draelos ZD, Marenus KD. Cellulite. Etiology and purported treatment. Dermatol Surg 1997; 23: 1177-81.
7. Piérard GE, Franchimont CP. Cellulite: From standing fat herniation to hypodermal stretch marks. Am J Dermatopathol 2000; 22: 34-7.
8. Byl N. The use of ultrasound as an enhancer for transcutaneous drug delivery: Phonophoresis. Phys Ther 1995; 75: 539-53.
9. Tang H, Mitragotri S, Blankschtein D, Langer R. Theoretical description of transdermal transport of hydrophilic permeants: Application to low-frequency sonophoresis. J Pharm Sci 2000; 90: 545-68.
10. Byl NN, Mckenzie A, Halliday B, Wong T, O'Connell J. The effects of phonophoresis with corticosteroids: A controlled pilot study. J Orthop Sports Phys Ther 1993; 18: 590-600.
11. Cagnie B, Vinck E, Rimbaurt S, Vanderstraeten G. Phonophoresis versus topical application of ketoprofen: Comparison between tissue and plasma levels. Phys Ther 2003; 707-12.
12. Ueda H, Ogihara M, Sugibayashi K, Morimoto Y. Difference in the enhancing effects of ultrasound on the skin permeation of polar and non-polar drugs. Chem Pharm Bull 1996; 44: 1973-6.
13. Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982; 62: 481-8.
14. Polacow MLO, Pires-de-Campos MSM, Leonardi GR et al. Efeito do ultra-som na permeação cutânea do tiratricol: Análise histológica. Rev Bras Fisioter 2004; 8: 53-60.
15. Ding ST, McNeel RL, O'Brian Smith E, Mersmann HJ. Modulation of porcine adipocyte β-adrenergic receptors by a β-adrenergic agonist. J Anim Sci 2000; 78: 919-29.
16. 3-adrenergic receptor subtype transcripts in porcine tissues. J Anim Sci 1999; 77: 611-21.
17. Rossi ABR, Vergnanini AL. Cellulite: A review. J Eur Acad Dermatol Venereol 2000; 14: 251-62.
18. Olfert ED, Cross BM, McWilliam AA. Guide to the Care Use of Experimental Animals, 1st edn, Vol. 1. Ottawa, ON: Canadian Council on Animal Care; 1993: 71-3.
19. Tyle P, Agrawala P. Drug delivery by phonophoresis. Pharm Res 1989; 6: 355-61.
20. Williams AR. Mechanical vibrations - Basic Physics. In: Ultrasound: Biologic Effects and Potential Hazards, 2nd edn. New York: Academic Press; 1983: 32-3.
21. Guirro RRJ, Cancelieri AS, Sant'Anna IL. Avaliação dos meios intermediários usados na aplicação do ultra-som terapêutico Rev. Bras Fisioter 2001; 5: 49-52.
22. Oakley EM. Apllication of continuous beam ultrasound at therapeutic levels. Physiother 1978; 64: 169-72.
23. De Lacerda CAM. Manual de Quantificação Morfológica: Morfometria, alometria e Esteriologia, 2nd edn. Rio de Janeiro, Brazil: CEBIO, 1994: 8-9.
24. Silva CA, Guirro RRJ, Polacow MLO, Cancelliero KM, Durigan JL. Rat hindlimb joint immobilization with acrylic resin orthoses. Braz J Med Biol Res 2006; 39: 979-85.
25. Pires-de-Campos MSM, Polacow MLO, Granzotto TM et al. Influence of the ultrasound in cutaneous permeation of the caffeine: In vitro study. Pharmacologyonline 2007; 1: 477-86.
26. Levang AK, Zhao K, Singh J. Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin. Int J Pharm 1999; 181: 255-63.
27. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm Res 2000; 17: 1354-9.
28. Mitragotri S, Blankschtein D, Langer R. Transdermal drug delivery using low frequency sonophoresis. Pharm Res 1996; 13: 411-20.
29. Rohrich RJ, Morales DE, Krueger JE et al. Comparative lipoplasty analysis of in vivo-treated adipose tissue. Plast Reconstr Surg 2000; 105: 2152-8.
30. Williams AR. Thermal effects of ultrasound. In: Ultrasound: Biologic Effects and Potential Hazards, 2nd edn. New York: Academic Press; 1983: 83-97.
31. Glick D, Adamovics A, Edemonds PD, Taenzer JC. Search for biochemical effects in cells and tissues of ultrasonic irradiation of mice and of the in vitro irradiation of mouse peritoneal and human amniotic cells. Ultrasound Med Biol 1979; 5: 23-33.
32. Cheung WT, Lee C, Ng TB. Potentiation of the anti-lipolytic effect of 2-chloroadenosine after chronic caffeine treatment. Pharmacology 1988; 36: 331-9.
33. Zhang Y, Wells JN. The effects of chronic caffeine administration on peripheral adenosine receptors. J Pharmacol Exp Therap 1990; 254: 757-63.
34. Lafontan M, Barbe P, Galitzky L et al. Adrenergic regulation of adipocyte metabolism. Hum Reprod 1997; 12: 6-20.
35. Massey LK. Caffeine and the elderly. Drugs Aging 1998; 13: 43-50.
36. Belilowsky M. Cellulite et caféine precutanée: études récentes sur percutaféine. C R Thér Pharmacol Clin 1988; 6: 23-7.
37. Lima BL, Vestri HS, Vestri S, Moraes SMF. L; Lipólise. In: R Curi, C Pompéia, CK Miyasaka, J Procopio, eds. Entendendo a gordura -os ácidos graxos, 1st edn. São Paulo, Brazil: Ed. Manole; 2002: 173-85.